Eroxon® Intense
Erectile Dysfunction (ED) - for stronger sensation
Pre-RegistrationProduct extension. Seeking regulatory approvals in USA, EU, and UK in 2025.
Key Facts
Indication
Erectile Dysfunction (ED) - for stronger sensation
Phase
Pre-Registration
Status
Product extension. Seeking regulatory approvals in USA, EU, and UK in 2025.
Company
About Futura Medical
Futura Medical has transitioned from a pre-revenue R&D group to a commercial-stage company with its lead product, Eroxon®, now available in over 15 countries worldwide. The company's strategy focuses on addressing the large, underserved OTC sexual health market through innovative, topically delivered gel formulations, with a pipeline that includes Eroxon® Intense and a women's health product, WSD4000. By partnering with leading consumer healthcare giants for marketing and distribution, Futura aims to leverage their resources and expertise to drive sales, build brand awareness, and achieve sustained profitability.
View full company profile